The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug ...

The assurance meeting is in two days. The team is gathered around a draft slide deck, not to ask what we can learn, change or adapt, but how to explain the position without being shouted at or ...

In new research being presented at the European Congress on Obesity in Istanbul, Turkey (12–15 May) and published in The ...

A study found a machine learning model more accurately predicted major adverse cardiac events, such as heart attacks, than ...

In new research to be presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) and published in ...

With AI taking on a more dominant role in clinical encounters, patient willingness to seek care is declining significantly. The researchers introduced a nuanced “intensity gradient,” ranging from ...

In new research to be presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) and published in The Journal of Nutrition ...

With global attention intensifying around the risks and governance of AI systems, a new study argues that current approaches remain too narrowly focused on technical solutions, overlooking deeper ...

1. FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results. News release. FDA. April 13, 2026.